- $2.19m
- -$3.60m
- $0.82m
Brief: Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel
Brief: Onconetix Announces 1-For-85 Reverse Stock Split
Brief: Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics
Brief: Onconetix Says Ralph Schiess Resigns As Interim CEO And Chief Science Officer
Brief: Onconetix Inc files for resale of up to 10.6 mln shares
Brief: Onconetix Inc offering up to 6,250,000 shares of common stock
Brief: Onconetix Inc - On June 8, Bruce Harmon Resigned As Chief Financial Officer Of Onconetix Effective Immediately.
Brief: Onconetix Announces Appointment Of Executives Dr. Ajit Singh And Dr. Thomas Meier To Board
Brief: Blue Water Biotech Acquires Proteomedix
Brief: Blue Water Biotech Signs Non-Binding Term Sheet To Acquire A Commercial Stage Oncology Company
Brief: Blue Water Biotech Issues Letter To Shareholders
Blue Water Biotech Inc expected to post a loss of 14 cents a share - Earnings Preview
Blue Water Biotech Inc reports results for the quarter ended in June - Earnings Summary
Brief: Blue Water Biotech Delivered Termination Notices Under Msa And Sows To Iqvia
Blue Water Biotech Inc expected to post a loss of 15 cents a share - Earnings Preview
Blue Water Biotech Inc expected to post a loss of 15 cents a share - Earnings Preview
Blue Water Biotech Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Blue Water Biotech Appoints Dr. Neil J. Campbell As President And CEO And Bruce Harmon As CFO
Blue Water Biotech Inc expected to post a loss of 15 cents a share - Earnings Preview